167

Cardiovascular Diseases
Focuses on heart and vascular health.
Sub Categories on Cardiovascular Diseases
Latest Articles
Bioinks with improved electromechanical properties for 3D printing of cardiac BioRings

Bioinks with improved electromechanical properties for 3D printing of cardiac BioRings

by Catherine Goulet-Cloutier,University of MontrealThe ring-shaped heart tissues are printed with a bioink containing a patient's stem cells. Credit: Véronique Lavoie, Chu Sainte-JustineScie

Bioinks with improved electromechanical properties for 3D printing of cardiac BioRings

by Catherine Goulet-Cloutier,University of MontrealThe ring-shaped heart tissues are printed with a bioink containing a patient's stem cells. Credit: Véronique Lavoie, Chu Sainte-JustineScie
Emergency department visit rate 72.2 per 1,000 adults with diabetes in 2020 to 2021

Emergency department visit rate 72.2 per 1,000 adults with diabetes in 2020 to 2021

by Elana GotkineIn 2020 to 2021, the emergency department visit rate was 72.2 visits per 1,000 adults with diabetes, with the rate increasing with age, according to a December data brief published by

Emergency department visit rate 72.2 per 1,000 adults with diabetes in 2020 to 2021

by Elana GotkineIn 2020 to 2021, the emergency department visit rate was 72.2 visits per 1,000 adults with diabetes, with the rate increasing with age, according to a December data brief published by
Does Mitral Valve Prolapse Cause Sudden Death?

Does Mitral Valve Prolapse Cause Sudden Death?

Does Mitral Valve Prolapse Cause Sudden Death?ByRichard N. Fogoros, MDUpdated on April 01, 2022Medically reviewed byAnisha Shah, MD窗体顶端Print窗体底端In the 2007 Chicago Marath

Does Mitral Valve Prolapse Cause Sudden Death?

Does Mitral Valve Prolapse Cause Sudden Death?ByRichard N. Fogoros, MDUpdated on April 01, 2022Medically reviewed byAnisha Shah, MD窗体顶端Print窗体底端In the 2007 Chicago Marath
Drug acoramidis to treat rare heart disease approved by FDA

Drug acoramidis to treat rare heart disease approved by FDA

by Hanae Armitage,Stanford UniversityCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration has approved adrug developed at Stanford Medicinethat offers hope to peopl

Drug acoramidis to treat rare heart disease approved by FDA

by Hanae Armitage,Stanford UniversityCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration has approved adrug developed at Stanford Medicinethat offers hope to peopl
Researchers say around 10% of deaths from coronary stenting, balloon angioplasty are preventable

Researchers say around 10% of deaths from coronary stenting, balloon angioplasty are preventable

by Noah Fromson,University of MichiganCredit: Justine Ross, Jacob Dwyer: Michigan MedicineEach year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally in

Researchers say around 10% of deaths from coronary stenting, balloon angioplasty are preventable

by Noah Fromson,University of MichiganCredit: Justine Ross, Jacob Dwyer: Michigan MedicineEach year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally in
Heart Disease Statistics and Risk Factors

Heart Disease Statistics and Risk Factors

Heart Disease Statistics and Risk FactorsWith a breakdown by populationByVanessa CaceresPublished on September 08, 2021Medically reviewed byRichard N. Fogoros, MD窗体顶端Print&nbsp

Heart Disease Statistics and Risk Factors

Heart Disease Statistics and Risk FactorsWith a breakdown by populationByVanessa CaceresPublished on September 08, 2021Medically reviewed byRichard N. Fogoros, MD窗体顶端Print&nbsp
Study finds mitochondrial activation in transplanted cells promotes regenerative therapy for heart failure

Study finds mitochondrial activation in transplanted cells promotes regenerative therapy for heart failure

by Hokkaido UniversityTreatment with human MITO cells (bottom right) effectively suppresses myocardial fibrosis in rat models with myocardial ischemia-reperfusion injury, compared to treatment wi

Study finds mitochondrial activation in transplanted cells promotes regenerative therapy for heart failure

by Hokkaido UniversityTreatment with human MITO cells (bottom right) effectively suppresses myocardial fibrosis in rat models with myocardial ischemia-reperfusion injury, compared to treatment wi
New research finds half-cardio, half-strength training reduces cardiovascular disease risks

New research finds half-cardio, half-strength training reduces cardiovascular disease risks

by Iowa State UniversityStructured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aero

New research finds half-cardio, half-strength training reduces cardiovascular disease risks

by Iowa State UniversityStructured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aero
Sinus Nodal Reentrant Tachycardia (SNRT) Symptoms and Treatment

Sinus Nodal Reentrant Tachycardia (SNRT) Symptoms and Treatment

Sinus Nodal Reentrant Tachycardia (SNRT) Symptoms and TreatmentByRichard N. Fogoros, MDUpdated on May 19, 2023Medically reviewed byYasmine S. Ali, MD, MSCISinus nodal reentrant

Sinus Nodal Reentrant Tachycardia (SNRT) Symptoms and Treatment

Sinus Nodal Reentrant Tachycardia (SNRT) Symptoms and TreatmentByRichard N. Fogoros, MDUpdated on May 19, 2023Medically reviewed byYasmine S. Ali, MD, MSCISinus nodal reentrant
Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

by Stephanie Lopez,Duke UniversityCredit: Pixabay/CC0 Public DomainAbout 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. T

Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

by Stephanie Lopez,Duke UniversityCredit: Pixabay/CC0 Public DomainAbout 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. T